4/A

FORM 4/A SUBMISSION

Company: Crinetics Pharmaceuticals, Inc.
Filed: April 4, 2022
Period of Report: January 3, 2022
Accession Number: 0001209191-22-022681

View Document ↗ View on SEC.gov ↗